GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulse Biosciences Inc (FRA:6L8) » Definitions » Other Current Liabilities

Pulse Biosciences (FRA:6L8) Other Current Liabilities : €1.64 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Pulse Biosciences Other Current Liabilities?

Pulse Biosciences's other current liabilities for the quarter that ended in Mar. 2024 was €1.64 Mil.

Pulse Biosciences's quarterly other current liabilities increased from Sep. 2023 (€2.11 Mil) to Dec. 2023 (€2.93 Mil) but then declined from Dec. 2023 (€2.93 Mil) to Mar. 2024 (€1.64 Mil).

Pulse Biosciences's annual other current liabilities declined from Dec. 2021 (€2.60 Mil) to Dec. 2022 (€1.30 Mil) but then increased from Dec. 2022 (€1.30 Mil) to Dec. 2023 (€2.93 Mil).


Pulse Biosciences Other Current Liabilities Historical Data

The historical data trend for Pulse Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulse Biosciences Other Current Liabilities Chart

Pulse Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pulse Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pulse Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Pulse Biosciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Pulse Biosciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulse Biosciences (FRA:6L8) Business Description

Traded in Other Exchanges
Address
3957 Point Eden Way, Hayward, CA, USA, 94545
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Pulse Biosciences (FRA:6L8) Headlines

No Headlines